GLENN LEVINE to Enoxaparin
This is a "connection" page, showing publications GLENN LEVINE has written about Enoxaparin.
Connection Strength
0.542
-
Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. J Thromb Thrombolysis. 2004 Jun; 17(3):167-71.
Score: 0.224
-
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35.
Score: 0.084
-
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol. 2010 Mar 04; 139(2):123-33.
Score: 0.076
-
Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendations. Catheter Cardiovasc Interv. 2003 Oct; 60(2):185-93.
Score: 0.053
-
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9.
Score: 0.053
-
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels. Thromb Res. 2003; 112(5-6):301-6.
Score: 0.051